KAPA
What one share of Kairos Pharma holds
Pharmaceutical Preparations
Kairos Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.28 |
|---|---|
| Cash and investments | $0.12 |
| Book value | $0.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$0.17 | — | $0.01 | — | −$0.20 |
| 2024 | — | −$0.23 | — | −$0.35 | — | $0.35 |
| 2025 | — | −$0.30 | — | −$0.19 | — | $0.30 |